Marker Therapeutics Inc (MRKR)

Marker Therapeutics (MRKR) Financial Statements


Marker Therapeutics Financial Overview

Marker Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.57; its P/E ratio is -1.92; Marker Therapeutics is scheduled to report earnings on November 14, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 762.66K-$ 3.31M$ 2.95M$ 0.00
Gross Profit$ 762.66K----
EBIT$ -4.10M$ -5.05M$ -2.10M$ -7.02M$ -9.28M
EBITDA$ -5.07M$ -4.08M$ -1.13M$ -5.98M$ -8.44M
Net Income Common Stockholders$ 2.52M$ -4.97M$ -2.10M$ -6.92M$ -9.24M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 18.10M$ 6.40M$ 11.78M$ 18.08M$ 25.82M
Total Assets$ 21.93M$ 27.91M$ 34.42M$ 41.11M$ 52.32M
Total Debt$ 0.00$ 7.49M$ 7.62M$ 7.72M$ 11.56M
Net Debt$ -18.10M$ 1.09M$ -4.17M$ -10.36M$ -14.26M
Total Liabilities$ 2.92M$ 12.03M$ 14.82M$ 18.51M$ 24.29M
Stockholders Equity$ 19.03M$ 15.91M$ 19.60M$ 22.60M$ 28.03M
Cash Flow-
Free Cash Flow$ -7.06M$ -5.89M$ -6.31M$ -7.75M$ -3.06M
Operating Cash Flow$ -7.06M$ -5.89M$ -6.31M$ -7.65M$ -794.71K
Investing Cash Flow$ 18.78M$ -112.61K$ -127.34K$ -99.37K$ -2.27M
Financing Cash Flow$ 736.00$ 619.97K$ 138.56K$ 0.00$ 63.57K
Currency in USD

Marker Therapeutics Earnings and Revenue History

Marker Therapeutics Debt to Assets

Marker Therapeutics Cash Flow

Marker Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis